Here are four points:
1. NuVasive stock dropped to $39.68 for a new 52-week low.
2. The stock has an average daily volume of 555,895 shares.
3. NuVasive’s 50-day moving average is $50.29, and its 200-day moving average is $50.11.
4. The company is entering the new trading day with a market cap of 2.01 billion.
More articles on devices:
FDA schedules meeting to review Cartiva’s PMA for synthetic cartilage implant: 4 points
Zimmer Biomet investors to offer 11M+ shares of common stock: 5 takeaways
Stryker director sells 12k shares, soon after Sage Products acquisition & potential Moody’s downgrade: 7 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
